Eur Rev Med Pharmacol Sci. 2023 Oct;27(5 Suppl):34-38. doi: 10.26355/eurrev_202310_34067.
ABSTRACT
OBJECTIVE: The aim of the study was to evaluate the changes in the quality of life of patients who underwent Type 1 tympanoplasty using the Chronic Otitis Media Questionnaire 12 (COMQ-12).
SUBJECTS AND METHODS: Prospectively collected data of patients aged between 18-65 years, who had undergone type 1 tympanoplasty between January 2018 to January 2019 were included in the study. The Turkish version of COMQ-12 was completed by all of the patients preoperatively as well as 12 months postoperatively. Preoperative and postoperative graft uptake outcomes, hearing assessment results, and scores of COMQ-12 were evaluated. Shapiro-Wilk test, Mann-Whitney U test, and Wilcoxon test were used.
RESULTS: A total of 98 patients were included. Noticeable improvement in the severity of symptoms, negative effect on daily life and work routine, health care, and general well-being was detected by subjective scores of the questionnaire. The COMQ-12 preoperative and postoperative overall average score was 25 and 7, respectively (p<0.001). Graft uptake success was found to be 85%. Hearing assessment evaluation showed a mean change in air conduction values of 8.78 (SD 1.17), and a mean change in air-bone gap values of 7 (SD 0.8), both showing statistical significance (p<0.001).
CONCLUSIONS: According to the COMQ-12 questionnaire data after surgery, symptom severity, lifestyle and work impact, health service impact, and general discomfort were significantly reduced.
PMID:37869945 | DOI:10.26355/eurrev_202310_34067
